Toss a bone to a newbie... What gives.
I dont know why anyone would buy, it clearly says on news articles court bans DNA patents. Now it is down cause everyone realizes.
The BRACAnalysis trademark now carries most of the value. This decision ought to end the substantial ongoing litigation expense Myriad was obliged by its contracts with University of Utah to undergo.
Patents - As many as 9 claims out of hundreds could be thrown out. They may save on royalties! Ha! Hardly bad news.
The ruling clarifies what direction you have to go to get rock solid patent protection vs endless litigation. That is why it is the plus for myriad.
Sentiment: Strong Buy
Now everybody can test the nature occurring BRCA gene mutation, the price will be down dramatically. Bad to MYGN!